FIVE STAR SENIOR LIVING INC (FVE)

US33832D1063 - Common Stock

2.94  +0.07 (+2.44%)

Fundamental Rating

1

FVE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 117 industry peers in the Health Care Providers & Services industry. FVE has a bad profitability rating. Also its financial health evaluation is rather negative. FVE does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year FVE has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -4.4%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 0.52%
PM (TTM) -1.57%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

The number of shares outstanding for FVE has been increased compared to 1 year ago.
Compared to 1 year ago, FVE has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.16 indicates that FVE is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.05 indicates that FVE is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 1.51 indicates that FVE should not have too much problems paying its short term obligations.
A Quick Ratio of 1.51 indicates that FVE should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51

1

3. Growth

3.1 Past

The earnings per share for FVE have decreased strongly by -117.90% in the last year.
FVE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.26%.
Measured over the past years, FVE shows a decrease in Revenue. The Revenue has been decreasing by -3.15% on average per year.
EPS 1Y (TTM)-117.9%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-283.33%
Revenue 1Y (TTM)-15.26%
Revenue growth 3Y-5.89%
Revenue growth 5Y-3.15%
Revenue growth Q2Q-23.52%

3.2 Future

The Earnings Per Share is expected to grow by 61.66% on average over the next years. This is a very strong growth
The Revenue is expected to decrease by -9.86% on average over the next years.
EPS Next Y-120%
EPS Next 2Y28.06%
EPS Next 3Y53.83%
EPS Next 5Y61.66%
Revenue Next Year-19.45%
Revenue Next 2Y-18%
Revenue Next 3Y-11.55%
Revenue Next 5Y-9.86%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

FVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year FVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.27

4.3 Compensation for Growth

FVE's earnings are expected to grow with 53.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.06%
EPS Next 3Y53.83%

0

5. Dividend

5.1 Amount

No dividends for FVE!.
Industry RankSector Rank
Dividend Yield N/A

FIVE STAR SENIOR LIVING INC

NASDAQ:FVE (1/27/2022, 7:26:29 PM)

2.94

+0.07 (+2.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap93.36M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.4%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 0.52%
PM (TTM) -1.57%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.81
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-117.9%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-120%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-15.26%
Revenue growth 3Y-5.89%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y